First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial
N
Shared by NobleBlocks on Nov 1, 2012 • 12:00 AM UTC
Authors:
Siow Ming Lee
,
Iftekhar Khan
,
Sunil Upadhyay
Finding related papers...
Discussions
(0)
No comments yet
Be the first to share your thoughts!
First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial | NobleBlocks
